We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$44.7B
AUM Growth
+$1.05B
Cap. Flow
-$219M
Cap. Flow %
-0.49%
Top 10 Hldgs %
14.74%
Holding
2,718
New
213
Increased
1,645
Reduced
764
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 17.85%
2 Healthcare 13.61%
3 Financials 12.57%
4 Industrials 12.51%
5 Consumer Discretionary 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVID
2551
DELISTED
Avid Technology Inc
AVID
$109K ﹤0.01%
20,703
+4,220
+26% +$21.7K
TESO
2552
DELISTED
Tesco Corp
TESO
$109K ﹤0.01%
24,546
+5,046
+26% +$27.8K
PKD
2553
DELISTED
Parker Drilling Company
PKD
$108K ﹤0.01%
5,310
+1,044
+24% +$23.5K
MGNI icon
2554
Magnite
MGNI
$3.55B
$107K ﹤0.01%
20,823
+4,760
+30% +$26.2K
PDSB icon
2555
PDS Biotechnology
PDSB
$43.4M
$106K ﹤0.01%
+514
New +$101K
NXEO
2556
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$106K ﹤0.01%
+12,814
New +$113K
CEMP
2557
DELISTED
Cempra, Inc.
CEMP
$106K ﹤0.01%
23,006
+5,848
+34% +$23.1K
CMRE icon
2558
Costamare
CMRE
$1.77B
$105K ﹤0.01%
+14,430
New +$101K
TBHC
2559
DELISTED
The Brand House Collective
TBHC
$105K ﹤0.01%
+10,231
New +$109K
UEC icon
2560
Uranium Energy
UEC
$5.57B
$104K ﹤0.01%
+65,225
New +$91K
VRS
2561
DELISTED
Verso Corporation
VRS
$104K ﹤0.01%
+22,118
New +$105K
FRTA
2562
DELISTED
Forterra, Inc
FRTA
$104K ﹤0.01%
+12,657
New +$165K
IBRX icon
2563
ImmunityBio
IBRX
$8.1B
$102K ﹤0.01%
+13,481
New +$58.2K
LCTX icon
2564
Lineage Cell Therapeutics
LCTX
$278M
$102K ﹤0.01%
37,143
+10,282
+38% +$28.7K
MNOV icon
2565
MediciNova
MNOV
$66M
$102K ﹤0.01%
19,341
+3,603
+23% +$20.2K
OCUL icon
2566
Ocular Therapeutix
OCUL
$2.02B
$102K ﹤0.01%
+10,979
New +$106K
VOXX
2567
DELISTED
VOXX International Corporation Class A
VOXX
$102K ﹤0.01%
+12,411
New +$78.8K
SQBG
2568
DELISTED
Sequential Brands Group, Inc.
SQBG
$102K ﹤0.01%
637
+174
+38% +$24.8K
STML
2569
DELISTED
Stemline Therapeutics, Inc.
STML
$102K ﹤0.01%
+11,069
New +$92.3K
MVIS icon
2570
Microvision
MVIS
$78.9M
$101K ﹤0.01%
+3,186
New +$103K
QMCO icon
2571
Quantum Corp
QMCO
$474M
$101K ﹤0.01%
+648
New +$101K
HSTO
2572
DELISTED
Histogen Inc. Common Stock
HSTO
$101K ﹤0.01%
+87
New +$106K
AXTI icon
2573
AXT Inc
AXTI
$5.8B
$100K ﹤0.01%
+15,801
New +$103K
GORO icon
2574
Goldgroup Mining Inc.
GORO
$191M
$100K ﹤0.01%
24,632
+7,632
+45% +$29K
PVLA
2575
Palvella Therapeutics
PVLA
$2.27B
$100K ﹤0.01%
+246
New +$71.9K

Similar funds

VOYA Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, VOYA Investment Management held 2,718 positions worth $44.7B, up 2.4% from $43.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

VOYA Investment Management's Q2 2017 filing shows 213 new, 1,645 increased, 764 reduced and 81 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 452,626 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $304M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • VOYA Investment Management's largest Q2 2017 buy was iShares 1-3 Year Treasury Bond ETF: 452,626 shares worth $38.2M.
  • VOYA Investment Management added most to Union Pacific in Q2 2017, an estimated $208M increase.
  • VOYA Investment Management's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $304M.
  • VOYA Investment Management fully exited Janus Capital Group Inc in Q2 2017, selling an estimated $29.6M.
  • VOYA Investment Management's ten largest holdings make up 15% of its $44.7B portfolio in Q2 2017.
  • VOYA Investment Management opened 213 new positions and closed 81 in Q2 2017.
  • VOYA Investment Management's portfolio value rose 2.4% quarter-over-quarter to $44.7B.

Based on VOYA Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.